Description: Summary of a talk by Robert J. Myers given at a recent meeting of the Baltimore Actuaries Club on revising the standard premium rate for Supplementary Medical Insurance.

Description: Teaching session on the working Medicare contracts: background on the origin of Medicare risk contracts, feasibility of an HMO or competitive medical plan entering the Medicare risk market, and outline of the HCFA adjusted community rate filing process.

Description: This is an article explaining the options employers have under the Medicare Part D, or the Prescription Drug Improvement and Medicare Modernization Act - MMA - that took effect in January 2006. The article discusses 4 options under the MMA with the advantages and disadvantages of each.

Description: This article focuses on mandatory supplemental benefits offered by general enrollment plans and Dual Eligible Special Needs Plans (D-SNPs) Medicare Advantage plans from 2017 to 2021.

Description: In this article, Dr. Ted LeBoy, Assistant Medical Director of Continental Assurance Co., commented on some changes that had been observed during the first eight months of Medicare's existence. These included changes in the average number of hospital days and physician charges.

Description: Issues relating to the1998 Balanced Budget Act BBA on Medicare Supplement Carriers. Discusses High-Deductible options, open enrollment provisions, pre-existing condition limitations, new provider payment methods and preventive benefits Issue No. 36.

Description: This article is about the Balanced Budget Act of 1997. This Act revises the Medicare landscape by the creation of Part C - Medicare+Choice, Medical Savings Accounts, payment reforms.

Description: This paper discusses the quality of healthcare verses the price of healthcare and puruses individuals and doctors making decisions for their own healthcare costs and services.

Description: A glossary of terms.

Description: In session 26PD of the 2004 Valuation Actuary Symposium, discussed is how the new Medicare prescription drug legislation creates a number of issues for employers and managed-care plans. Employers must determine the impact of the legislation on their retiree prescription drug costs, evaluate options for plan design and make decisions about how to reflect the effect of the legislation in their FAS 106 valuations. Managed-care plans need to review the effect of the legislation on plan design, statutory filings and financial reporting for their Medicare products.